Greiner Bio-One Exhibits Its New Generation of Sapphire Pipette Tips at MEDICA 2021
By LabMedica International staff writers Posted on 16 Nov 2021 |
Greiner Bio-One (Monroe, NC, USA) exhibited its new generation of Sapphire pipette tips at MEDICA 2021, the leading international trade fair for the medical sector. More than 5,000 exhibitors from 70 countries presented their newest products and ideas at this year’s MEDICA which drew 120,000 trade visitors from over 170 countries.
At MEDICA 2021, Greiner presented its new generation of Sapphire pipette tips which are perfect flexibility for laboratory liquid handling and were launched in September. The tips are made of medical polypropylene and benefit from a universal fit on most standard pipettes. They are available in standard, filter, low-retention and filter low-retention versions. By minimizing the adhesion of sample material on the inside of the tip, the low-retention surface ensures maximum precision, even with detergents and other viscous or complex samples. The filter tips reliably prevent the transfer of biological material and aerosols, without this negatively affecting the accuracy of the volume being pipetted. No additives are used when manufacturing the filters. Even after accidental contact, it is therefore possible to continue using samples. In conjunction with Sapphire pipettes, the universal tips offer a fully optimized and harmonized liquid handling solution from a single source. The new pipette tips are produced and packaged at the company’s Austrian plant in Kremsmünster, in a fully automated process that minimizes any potential risk of contamination.
Greiner also showcased its new VACUETTE Virus Stabilization Tube that supports the safe transport and storage of specimens, including COVID-19 swab samples. The company demonstrated how its VACUETTE Virus Stabilization Tube can help alleviate some of the barriers to testing for SARS-CoV-2 that laboratories are experiencing. VACUETTE Virus Stabilization Tubes are intended for the transport and storage of nasopharyngeal and oropharyngeal swab specimens. Meant for use by healthcare professionals for SARS-CoV-2 testing only, VACUETTE Virus Stabilization Tubes are made of PET with a pre-defined volume of a phosphate buffer saline solution at a pH of 7.4±0.2 to allow for the storage of the SARS-CoV-2 swab specimens for up to 72h at 4°C. The tubes are fitted with VACUETTE Safety Caps and the tube interior is sterile. The product is single use only and can be used on a single patient only. The CE-marked VACUETTE Virus Stabilization Tubes are manufactured according to Greiner’s hygienic standards.
Related Links:
Greiner Bio-One
Latest Molecular Diagnostics News
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans
- Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
- Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
- Low-Cost Point-Of-Care Diagnostic to Expand Access to STI Testing
- 18-Gene Urine Test for Prostate Cancer to Help Avoid Unnecessary Biopsies
- Urine-Based Test Detects Head and Neck Cancer
- Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer
- Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer
- Simple PCR Assay Accurately Differentiates Between Small Cell Lung Cancer Subtypes
- Revolutionary T-Cell Analysis Approach Enables Cancer Early Detection